Comparative Binding Energy (COMBINE) Analysis Supports a Proposal for the Binding Mode of Epothilones to β‐Tubulin
暂无分享,去创建一个
F. Gago | A. Morreale | J. F. Díaz | J. Klett | C. Coderch | J. Díaz
[1] J. Snyder,et al. The solid state, solution and tubulin-bound conformations of agents that promote microtubule stabilization. , 2012, Current medicinal chemistry. Anti-cancer agents.
[2] K. Altmann,et al. The biology and medicinal chemistry of epothilones. , 2012, Current medicinal chemistry. Anti-cancer agents.
[3] J. Snyder,et al. C6-C8 bridged epothilones: consequences of installing a conformational lock at the edge of the macrocycle. , 2011, Chemistry.
[4] George M. Whitesides,et al. Mechanism of the hydrophobic effect in the biomolecular recognition of arylsulfonamides by carbonic anhydrase , 2011, Proceedings of the National Academy of Sciences.
[5] K. Altmann,et al. Diversity through semisynthesis: the chemistry and biological activity of semisynthetic epothilone derivatives , 2011, Molecular Diversity.
[6] Marcel Knossow,et al. The determinants that govern microtubule assembly from the atomic structure of GTP-tubulin. , 2011, Journal of molecular biology.
[7] Tjelvar S. G. Olsson,et al. Extent of enthalpy–entropy compensation in protein–ligand interactions , 2011, Protein science : a publication of the Protein Society.
[8] E. Mandelkow,et al. Interaction of epothilone B (patupilone) with microtubules as detected by two-dimensional solid-state NMR spectroscopy. , 2010, Angewandte Chemie.
[9] C. Dumontet,et al. Microtubule-binding agents: a dynamic field of cancer therapeutics , 2010, Nature Reviews Drug Discovery.
[10] A. Navarro‐Vázquez,et al. The Binding Mode of Side Chain‐ and C3‐Modified Epothilones to Tubulin , 2010, ChemMedChem.
[11] Arieh Warshel,et al. A comprehensive examination of the contributions to the binding entropy of protein–ligand complexes , 2010, Proteins.
[12] K. Altmann,et al. Evaluation of Novel Epothilone Analogues by means of a Common Pharmacophore and a QSAR Pseudoreceptor Model for Taxanes and Epothilones , 2010, ChemMedChem.
[13] Antonio Morreale,et al. gCOMBINE: A graphical user interface to perform structure‐based comparative binding energy (COMBINE) analysis on a set of ligand‐receptor complexes , 2010, Proteins.
[14] J. Hunt. Discovery of Ixabepilone , 2009, Molecular Cancer Therapeutics.
[15] Adnan Memic,et al. How Do Halogen Substituents Contribute to Protein‐Binding Interactions? A Thermodynamic Study of Peptide Ligands with Diverse Aryl Halides , 2008, Chembiochem : a European journal of chemical biology.
[16] R. Himes,et al. The paclitaxel site in tubulin probed by site‐directed mutagenesis of Saccharomyces cerevisiae β‐tubulin , 2008, FEBS letters.
[17] Federico Gago,et al. Optimization of taxane binding to microtubules: binding affinity dissection and incremental construction of a high-affinity analog of paclitaxel. , 2008, Chemistry & biology.
[18] S. Swain,et al. The Epothilones: Translating from the Laboratory to the Clinic , 2008, Clinical Cancer Research.
[19] K. Altmann,et al. Conformational preferences of natural and C3-modified epothilones in aqueous solution. , 2008, Journal of medicinal chemistry.
[20] Gerald H Lushington,et al. Whither combine? New opportunities for receptor-based QSAR. , 2007, Current medicinal chemistry.
[21] T. Carlomagno,et al. High‐Resolution Solid‐State NMR Structure of an Anticancer Agent , 2007, ChemMedChem.
[22] K. Nicolaou,et al. The Chemistry and Biology of Epothilones—The Wheel Keeps Turning , 2007, ChemMedChem.
[23] Jens Meiler,et al. Structural basis of the activity of the microtubule-stabilizing agent epothilone a studied by NMR spectroscopy in solution. , 2007, Angewandte Chemie.
[24] J. Snyder,et al. Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of β-tubulin (Asp26Glu) and less stable microtubules , 2006, Molecular Cancer Therapeutics.
[25] Lenwood S. Heath,et al. H++: a server for estimating pKas and adding missing hydrogens to macromolecules , 2005, Nucleic Acids Res..
[26] W. Schubert,et al. Lange gesucht – die bioaktive Konformation von Epothilon und seine Bindung im Tubulin , 2005 .
[27] D. Heinz,et al. Much anticipated--the bioactive conformation of epothilone and its binding to tubulin. , 2005, Angewandte Chemie.
[28] Richard E. Taylor,et al. Conformation-activity relationships in polyketide natural products. Towards the biologically active conformation of epothilone. , 2004, Organic & biomolecular chemistry.
[29] Ben Cornett,et al. The Binding Mode of Epothilone A on α,ß-Tubulin by Electron Crystallography , 2004, Science.
[30] David Baker,et al. Protein structure prediction and analysis using the Robetta server , 2004, Nucleic Acids Res..
[31] Federico Gago,et al. Chemometrical identification of mutations in HIV-1 reverse transcriptase conferring resistance or enhanced sensitivity to arylsulfonylbenzonitriles. , 2004, Journal of the American Chemical Society.
[32] A. Ritzén,et al. Interaction of epothilone analogs with the paclitaxel binding site: relationship between binding affinity, microtubule stabilization, and cytotoxicity. , 2004, Chemistry & biology.
[33] T. Poulos,et al. Crystal Structures of Epothilone D-bound, Epothilone B-bound, and Substrate-free Forms of Cytochrome P450epoK* , 2003, Journal of Biological Chemistry.
[34] Jens Meiler,et al. The high-resolution solution structure of epothilone A bound to tubulin: an understanding of the structure-activity relationships for a powerful class of antitumor agents. , 2003, Angewandte Chemie.
[35] Claudia J. Bode,et al. Understanding tubulin–Taxol interactions: Mutations that impart Taxol binding to yeast tubulin , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[36] Claudia J. Bode,et al. Epothilone and paclitaxel: unexpected differences in promoting the assembly and stabilization of yeast microtubules. , 2002, Biochemistry.
[37] E. Nogales,et al. Refined structure of alpha beta-tubulin at 3.5 A resolution. , 2001, Journal of molecular biology.
[38] S. Horwitz,et al. MUTATIONS IN BETATUBULIN MAP TO DOMAINS INVOLVED IN REGULATION OF MICROTUBULE STABILITY IN EPOTHILONE-RESISTANT CELL LINES , 2001 .
[39] R. Wade,et al. Microtubule structure at improved resolution. , 2001, Biochemistry.
[40] K. Varani,et al. Can thermodynamic measurements of receptor binding yield information on drug affinity and efficacy? , 2000, Biochemical pharmacology.
[41] Y. Engelborghs,et al. Molecular Recognition of Taxol by Microtubules , 2000, The Journal of Biological Chemistry.
[42] D. Kingston,et al. A common pharmacophore for Taxol and the epothilones based on the biological activity of a taxane molecule lacking a C-13 side chain. , 2000, Biochemistry.
[43] E. Nogales,et al. A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[44] S. Kuduk,et al. A common pharmacophore for cytotoxic natural products that stabilize microtubules. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[45] E. Nogales,et al. High-Resolution Model of the Microtubule , 1999, Cell.
[46] David S. Goodsell,et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..
[47] M Pastor,et al. Comparative binding energy analysis of HIV-1 protease inhibitors: incorporation of solvent effects and validation as a powerful tool in receptor-based drug design. , 1998, Journal of medicinal chemistry.
[48] K. Nicolaou,et al. Designed Epothilones: Combinatorial Synthesis, Tubulin Assembly Properties, abd Cytotoxic Action against Taxol-Resistant Tumor Cells† , 1997 .
[49] K. Nicolaou,et al. Gezielt entworfene Epothilone: kombinatorische Synthese, Induktion der Tubulin‐Polymerisation und cytotoxische Wirkung gegen taxolresistente Tumorzellen , 1997 .
[50] H. Reichenbach,et al. Epothilon A und B – neuartige, 16gliedrige Makrolide mit cytotoxischer Wirkung: Isolierung, Struktur im Kristall und Konformation in Lösung† , 1996 .
[51] H. Reichenbach,et al. Epothilone A and B—Novel 16-Membered Macrolides with Cytotoxic Activity: Isolation, Crystal Structure, and Conformation in Solution† , 1996 .
[52] H Irschik,et al. Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria). Production, physico-chemical and biological properties. , 1996, The Journal of antibiotics.
[53] E. Lazarides,et al. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. , 1995, Cancer research.
[54] P. Kollman,et al. A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char , 1993 .
[55] T. Darden,et al. Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .
[56] P. Goodford. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.
[57] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[58] G. Ciccotti,et al. Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .
[59] Marcel Knossow,et al. The binding of vinca domain agents to tubulin: structural and biochemical studies. , 2010, Methods in cell biology.
[60] Gerhard Klebe,et al. Adding calorimetric data to decision making in lead discovery: a hot tip , 2010, Nature Reviews Drug Discovery.
[61] H. Abdi. Partial least squares regression and projection on latent structure regression (PLS Regression) , 2010 .
[62] I. Barasoain,et al. Fluorescent taxoid probes for microtubule research. , 2010, Methods in cell biology.
[63] G. Scuseria,et al. Gaussian 03, Revision E.01. , 2007 .
[64] James M. Briggs,et al. Comparative molecular field analysis (CoMFA) study of epothilones – tubulin depolymerization inhibitors: Pharmacophore development using 3D QSAR methods , 2001, J. Comput. Aided Mol. Des..